Postpartum NSAIDS and Maternal Hypertension

Status unconfirmed · Phase 4

Conditions studied: Preeclampsia, Gestational Hypertension, Superimposed Preeclampsia, Chronic Hypertension in Obstetric Context

In brief

Previous studies have suggested that NSAID use causes an increase in blood pressure. Further, blood pressure elevation has been noted in women with pregnancy related hypertensive disease during the postpartum period. NSAIDs remain part of standard postpartum care in women with hypertensive disease. The objective of this study is to determine whether postpartum standard care withholding NSAID use is associated with a clinically significant reduction in postpartum hypertension in women with pregnancy induced hypertension. The investigators hypothesize that women with pregnancy induced hypertensive disease will be half as likely to have blood pressure elevation of 150/100 mmHg in the first 24 hours postpartum. This study is an open label randomized trial of women with antepartum hypertension. Women will be randomized to receive standard postpartum care or standard postpartum care without NSAIDs. Blood pressure measurements and patient outcomes will be recorded. The study period will begin at the time of delivery and will end at the time of hospital discharge.

Key facts

Study ID

NCT03824119

Run by

University of Southern California

People needed

200

Starts

2018-12-11

Expected to finish

2022-12-11

Last updated by the study team

2020-11-06

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women 18 years or older delivering at LAC/USC Hospital
• Delivery occurring at or after 20 weeks gestation
• Diagnosis of antenatal hypertensive disorder: gestational hypertension, preeclampsia without severe features, preeclampsia with severe features, superimposed preeclampsia, eclampsia, chronic hypertension

You may not qualify if…

• HELLP Syndrome
• Renal dysfunction (Serum Creatinine >1.1 in current pregnancy)
• Known liver disease
• Low platelet count (<50,000 during hospital admission)
• Known sensitivity or allergy to ibuprofen or acetaminophen
• Use of therapeutic doses of anticoagulation
• Postpartum hemorrhage requiring blood transfusion
• Neonate with platelet disorder or thrombocytopenia in breastfeeding mother

Where it is running

• LA County Hospital/University of Southern California — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.